The latest from BioStock
» End of shortage – Novo products fully available in the US again
» Paxman retreats despite stable report
» Medivir's investigators report positive results directly from EASL
» Elekta increases its footprint in Latin America
» Pharming Technologies closes Abliva deal – forced redemption initiated
Read the newsletter for v.8 here.
The latest news
announces that the first liver tissue sampling with EndoDrill GI has been performed in the USA. Read more.
Immunovia begins recruiting for a new CFO ahead of commercialization in the US. Read more.
Qlife has successfully verified the biomarkers related to the previously announced LOI. Read moreThe company also informs that the subscription period in its rights issue expires on Tuesday, February 25, 2025. Read more.
Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer. Read more.
Teva and Alvotech announces that SELARSDI injection is now available in the United States. Read more.
Subscription period in QUIA PHARMAs A rights issue of units has been initiated. Read more.
Suggestions from Modulights shareholders' nomination board for the 2025 Annual General Meeting. Read more.
RaySearch Laboratories publishes correction. Read more.
sectra informs about the collaboration with Siemens Healthcare. Read more.
Hansa Biopharma will be attending TD Cowen's 45th Annual Health Care Conference. Read more.
Reports
Modulight S2Medical SensoDetect Toleranzia